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Studies of HIV-1 capsid formation in a cell-free system revealed that capsid assembly occurs via an ordered series of
assembly intermediates and requires host machinery. Here we use this system to examine 12 mutations in HIV-1 Gag that
others studied previously in intact cells. With respect to capsid formation, these mutations generally produced the same
phenotype in the cell-free system as in cells, indicating the cell-free system’s high degree of fidelity. Analysis of assembly
intermediates reveals that a mutation in the distal region of CA (322 LDS) and truncations proximal to the second cys-his box
in NC block multimerization of Gag at early stages in the cell-free capsid assembly pathway. In contrast, mutations in the
region of amino acids 56–68 (located in the proximal portion of MA) inhibit assembly at a later point in the pathway. Other
mutations, including truncations distal to the first cys-his box in NC and mutations in the distal half of MA (88HDG, 85YDG,
D104–115, and D115–129), do not affect formation of immature capsids in the cell-free system. These data provide new
information on the role of different domains in Gag during the early events of capsid assembly. © 2001 Academic Press
F
s
o
i
p
c
p
p
L
t
t
oINTRODUCTION
The assembly of the HIV-1 core, or capsid, involves a
complex series of events (reviewed in Wills and Craven,
1991; Gelderblom, 1991; Krausslich and Welker, 1996;
Boulanger and Jones, 1996; Freed, 1998; Garnier et al.,
1998). Pr55 Gag precursor polypeptides are synthesized
in the cytoplasm of the host cell, myristoylated cotrans-
lationally, and then targeted to the cytoplasmic side of
the plasma membrane. There they multimerize to form
spherical immature capsids that subsequently become
enveloped by the plasma membrane. As the enveloped
immature particles are released, the HIV-1 protease
cleaves Pr55 Gag into Pr17 (matrix or MA), Pr24 (capsid
or CA), Pr7 (nucleocapsid or NC), and Pr6. These late
cleavage events transform the immature spherical cap-
sid into the mature, bullet-shaped core.
When HIV-1 Gag is the only viral protein expressed in
cells, particles closely resembling enveloped immature
capsids are produced, indicating that Gag is the only
viral gene product required for immature capsid assem-
bly. Numerous studies expressing mutations in Gag
within mammalian cells revealed that specific regions of
Gag are important for assembly (reviewed in Wills and
Craven, 1991; Gelderblom, 1991; Krausslich and Welker,
1996; Boulanger and Jones, 1996; Freed, 1998; Garnier et
al., 1998). Exactly how these regions of Gag act to pro-
mote the proper multimerization of approximately 1500o1 To whom correspondence and reprint requests should be ad-
ressed. Fax: (206) 543-3873. E-mail: jais@u.washington.edu.
257Gag polypeptides into a single immature capsid has not
yet been elucidated. This significant gap in our under-
standing of the assembly process exists because early
events in capsid formation are difficult to detect and
study in cellular systems.
Recently, insights into these events were gained by
taking a biochemical approach to capsid assembly, us-
ing cell-free systems. In these experiments, cell-lysates,
which can be readily manipulated, are used to support
synthesis of Gag and its assembly into particles that
closely resemble immature capsids produced in mam-
malian cells (Spearman and Ratner, 1996; Lingappa et
al., 1997). Dissection of this system revealed that ATP
and a host protein or protein complex are required for
posttranslational events in cell-free capsid formation,
demonstrating for the first time the importance of host
machinery in capsid assembly (Lingappa et al., 1997).
urthermore, in the same study pulse-chase analysis
howed that Gag multimerization in the cell-free system
ccurs through stepwise formation of discrete assembly
ntermediates that progress from 10S to 80S to 150S and
ossibly 500S in size, culminating in the formation of the
ompletely assembled 750S immature capsid. These
osttranslational intermediates, composed of Gag
olypeptides as well as one or more host proteins (J. R.
ingappa, unpublished data), can be distinguished by
heir relatively discrete sizes upon velocity sedimenta-
ion (Lingappa et al., 1997). Together, they define an
rdered pathway of assembly intermediates, as previ-
usly described (Lingappa et al., 1997). Complexes re-
sembling these cell-free assembly intermediates were
0042-6822/01 $35.00
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258 SINGH, HILL, AND LINGAPPAalso identified in mammalian cells expressing HIV-1 Gag
(Lingappa et al., 1997; Lee and Yu, 1998; Lee et al., 1999).
n comparison to cellular systems, the cell-free system
ccumulates much larger quantities of assembly inter-
ediates, making it advantageous for studying the cap-
id assembly process.
To gain a better understanding of the role of domains
n Gag during the early events in capsid formation, we
nalyzed cell-free reactions programmed with mutants in
ag whose effects on particle formation in cellular sys-
ems were previously described by others. An initial
xamination of four well-known mutants in Gag revealed
hat their phenotypes, with respect to capsid assembly,
ere faithfully reproduced in the cell-free system (Lin-
appa et al., 1997). Interestingly, that study revealed that
ifferent mutants result in accumulation of specific sub-
ets of assembly intermediates, suggesting that different
omains of Gag are required for progression from one
ssembly intermediate to the next. In the present study,
e examined the phenotypes with respect to capsid
ssembly and the formation of assembly intermediates
or 12 additional mutations in Gag (diagrammed in Fig. 1),
even of which involve point mutations (87VDE, 85YDG,
8HDG, and 59IDE) or deletions (D56–68, D104–115, and
115–129) in MA. One is located in the distal third of CA
322 LDS) and four involve progressive truncations in NC
between residues 390 and 430 (Pr41.9, Pr44.2, Pr44.3,
and Pr45). One striking finding of this study is that the
assembly phenotypes found in the cell-free system cor-
respond closely to the phenotypes that other investiga-
tors found in cells. In addition, analysis of intermediates
produced in the cell-free system suggests that residues
in the distal region of CA and the adjacent proximal
region of NC are involved in the early stages of Gag
multimerization. In contrast, other residues (for example,
in certain regions of the MA domain and in the proximal
portion of CA) appear to have effects on late events in
immature capsid formation.
RESULTS
In the cell-free system, Gag transcripts are trans-
lated in the presence of a cellular extract that contains
soluble factors necessary for translation and assem-
bly, as well as membranes (plasma membranes and
other cellular membranes) required for proper capsid
formation, as described in Lingappa et al. (1997). The
formation of bona fide capsids in this system was
previously confirmed by a variety of different tech-
niques (Lingappa et al., 1997). In the current study,
cell-free reactions were programmed with wild-type vs
mutant forms of Gag, and allowed to translate and
assemble for 150 min. The total amount of wild-type or
mutant Gag synthesized in each reaction was the
same (see bar graphs in Figs. 2–6). Upon completion
of the assembly reaction, Nonidet P-40 (NP-40), anonionic detergent, was added to 1% to remove mem-
branes associated with capsids, allowing protein com-
plexes containing Gag to be studied in isolation. The
reaction products were then subjected to velocity sed-
imentation on 13-ml gradients. We previously showed
that this technique allows posttranslational Gag-con-
taining complexes of different sizes (approximately
10S, 80S, 150S, 500S, and completed 750S capsids) to
be resolved, that these complexes appear in an or-
dered fashion over time, and that those less than 750S
in size most likely correspond to assembly intermedi-
ates. In addition, we previously demonstrated by both
biochemical and ultrastructural analyses that the 750S
complex closely resembles completely assembled im-
mature capsids produced in transfected mammalian
cells (Lingappa et al., 1997). To further confirm that the
assembly intermediates represent protein complexes
of different S values, we examined the migration of
these complexes when subjected to a much longer
centrifugation that should place complexes of 10S and
greater toward the bottom of the gradient. As pre-
dicted, all the assembly intermediates migrated in
together in the pellet under these conditions (Fig. 1B,
open circles). This indicates that in our standard gra-
dients, assembly intermediates are being separated
on the basis of their S values, not their densities.
Effect of mutations in NC and distal CA on capsid
formation in the cell-free system
One group of mutations we examined is located in the
NC region of Gag, which contains two cysteine-histidine
(cys-his)-rich regions as well as highly basic residues
flanking either side of the first cys-his box. The NC region
of Gag is thought to play an important role in both
particle formation and RNA packaging (reviewed in
Berkowitz et al., 1996; Freed, 1998). Studies using ex-
pression in insect cells demonstrated that, when Gag is
truncated just proximal to the second cys-his box in NC,
particle formation closely resembles that of wild-type
Gag by biochemical and morphological criteria (Jowett et
al., 1992; Hockley et al., 1994). These studies also
showed that particles of the correct density and morphol-
ogy fail to form when both cys-his boxes and all their
adjacent basic residues are removed. Similar results
were obtained using transfected mammalian cells
(Zhang and Barklis, 1997; Dawson and Yu, 1998). Further
investigation revealed that multiple regions of NC are
important for Gag–Gag interactions, including the N-
terminal of NC, the first cys-his box, and residues distal
to the first cys-his box (Sandefur et al., 2000). Since the
cell-free assembly pathway allows for a detailed analysis
of such Gag–Gag interactions, we examined the capsid
assembly phenotypes that result from truncations in NC.Truncation mutants were constructed by inserting a
stop codon after residues located in and around the two
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259EFFECT OF MUTATIONS ON CELL-FREE HIV-1 CAPSID ASSEMBLYcys-his boxes, as described under Materials and Meth-
ods and diagrammed in Fig. 1. The nomenclature we
used for these mutations was similar to that used by
Jowett et al. (1992). We previously demonstrated that the
mutant Pr41, which is truncated proximal to the first
residue of NC, is assembly-defective in the cell-free
system, and results in accumulation of large amounts of
only the first (10S) assembly intermediate (Lingappa et
al., 1997). Similar results were obtained when cell-free
FIG. 1. (A) Diagram showing location of mutations expressed in th
domains: MA, CA, NC, and Pr6, whose junctions are indicated with
constructed and expressed for this study include seven mutations in M
ne mutation in CA (322 LDS), as indicated by filled boxes in the diagra
n NC that were also examined in this study (Pr41.9, Pr44.2, Pr44.3, an
reviously in the cell-free system (Lingappa et al., 1997). The arrows ind
ndicate the residues that comprise the first and second cys-his box
edimentation. Cell-free translation and assembly reactions were progr
he end of the incubation, NP-40 was added to 1%. One aliquot of pro
inear sucrose gradients containing 1% NP-40 using parameters (35,00
howed to optimize separation of HIV-1 capsid assembly intermediat
entrifuged using the same gradients and rotor at 40,000 rpm for 140 h. T
he amount of radiolabeled translation product in each fraction was dereactions were programmed with the longer truncation
mutant Pr41.9 (Fig. 2), which removes both cys-his boxesand most but not all of the adjacent basic residues of NC,
as shown in Fig. 1. In contrast, accumulation of the 750S
completed capsid was observed when cell-free reac-
tions were programmed with Pr44.2 (Fig. 2), in which the
entire first cys-his box and its highly basic flanking res-
idues are intact but the second cys-his box is completely
removed. Successive truncations that express part or all
of the second cys-his box (Pr44.3 and Pr45, shown in Fig.
2) also resulted in accumulation of the completed 750S
free HIV capsid assembly system. HIV-1 Gag (Pr55) consists of four
lines. The NC domain starts at residue 380. Mutations that were
DE, D 56–68, 85 YDG, 87 VDE, 88 HDG, D104–115, and D115–129), and
p. The inset below shows the exact position of four truncation mutants
, and two truncation mutants in NC (Pr41 and Pr46) that were studied
e last amino acid before the stop codon for each mutation. Open boxes
ag, respectively. (B) Analysis of assembly intermediates by velocity
with transcript encoding wild-type Gag and incubated for 150 min. At
spin 1, filled circles) was analyzed by velocity sedimentation on 13-ml
using a Beckman SW40 Ti rotor for 95 min at 4°C) that we previously
gappa et al., 1997). An equivalent aliquot (spin 2, open circles) was
er centrifugation would be expected to pellet particles of 10S or greater.
d and expressed as a percentage of total synthesis for each reaction.e cell-
narrow
A (59 I
m on to
d Pr45)
icate th
es of G
ammed
ducts (
0 rpm
es (Lincapsid. Together, these data demonstrate that, in the
cell-free system, completed immature capsids of the
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260 SINGH, HILL, AND LINGAPPAcorrect size are produced in the absence of the second
cys-his box, but not when both cys-his boxes and their
adjacent basic residues are removed.
In addition, we observed that cell-free expression of
the assembly-competent truncation mutants Pr44.2,
Pr44.3, and Pr45 resulted in accumulation of variable
amounts of residual early assembly intermediates (10S
FIG. 2. Velocity sedimentation analysis of truncation mutants in the
rogrammed with transcript encoding the Pr41.9, Pr44.2, Pr44.3, and P
P-40 was added to 1%, and reaction products were analyzed by v
escribed under Materials and Methods. The amount of radiolabeled
ercentage of total synthesis for each reaction. Reactions and gradient a
imes; two representative experiments are shown (open circles vs fille
ar graph and described under Materials and Methods.and 80S), as is seen with wild-type Gag. Inclusion of
progressively more of the second cys-his box appears toshift the reaction toward production of larger amounts of
the 750S capsid and 80S intermediate, and smaller
amounts of the 10S assembly intermediate (Fig. 2). Since
resolution of the 10S and 80S peaks is limited using the
gradients shown in Fig. 2, we optimized the analysis of
these two peaks by examining their appearance at dif-
ferent time points using velocity sedimentation gradients
ion of Gag. Cell-free translation and assembly reactions (12 ml) were
tations in HIV-1 Gag (see Fig. 1A). At the end of the 150-min reaction
sedimentation on 13-ml sucrose gradients containing 1% NP-40, as
lation product in each fraction was determined and expressed as a
s were performed in parallel with a wild-type control three independent
s). Total cell-free reaction products were quantitated as shown in theNC reg
r45 mu
elocity
trans
nalysethat optimize separation of the 10S and 80S intermedi-
ates (described under Materials and Methods). These
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261EFFECT OF MUTATIONS ON CELL-FREE HIV-1 CAPSID ASSEMBLYexperiments revealed that the amount of the 80S inter-
mediate is greatest at 30–45 min into the cell-free reac-
tion (data not shown), as would be expected from our
previous pulse-chase data (Lingappa et al., 1997). Com-
arison of the different truncation mutants in parallel at
5 min (using gradients that resolve in the 10S to 100S
ange) demonstrates that including additional amino ac-
ds in the proximal region of NC leads to increasing
ormation of the 80S intermediate. Thus, Pr41 forms no
0S intermediate (Figs. 2 and 3, and Lingappa et al.,
997), and Pr41.9 resembles Pr41 (Fig. 3). In contrast,
r44.2 and Pr44.3 have progressively larger peaks in the
FIG. 3. Analysis of NC truncations and the production of the 80S
rogrammed with transcripts encoding the Pr41.0, Pr41.9, Pr44.2, and P
y each of these reactions was examined at 30, 45, 60, and 90 min usi
ot shown). Reactions were then programmed for all four mutations in
liminate polysomes, NP-40 was added to 1%, and reaction products
radients containing 1% NP-40 as described under Materials and Meth
s previously described (Lingappa et al., 1994). (A) The experiment was
ell-free reaction products were quantitated as shown in the bar grap0S region. The 80S peak was even more prominent
or Pr45 and Pr46 than for Pr44.3 (Fig. 2 and data not
p
Fhown). Together, these data suggest that residues in
C between 390 and 414 play a role in allowing Gag
hains to progress beyond the first assembly intermedi-
te in the cell-free capsid assembly pathway.
We examined whether mutations in other regions of
ag, besides NC, might also result in blockade at early
teps in the assembly pathway. We constructed a point
utation, 322 LDS (in the distal region of CA) that was
reviously found to be assembly-defective when ex-
ressed in insect cells (Hong and Boulanger, 1993).
hen the cell-free system was programmed with tran-
cript for 322 LDS, no completed 750S capsids were
bly intermediate. Cell-free translation and assembly reactions were
utations in HIV-1 Gag. The amount of the 80S intermediate produced
city sedimentation gradients, and found to be maximal at 45 min (data
l. Reactions were incubated for 45 min, EDTA was added to 10 mM to
subjected to velocity sedimentation analysis on 2-ml linear sucrose
e position of an 80S complex was determined using S-value standards
ted three times, and one representative experiment is shown. (B) Total
escribed under Materials and Methods.assem
r44.3 m
ng velo
paralle
were
ods. Throduced (Fig. 4). Analysis of assembly intermediates in
ig. 3 revealed that the 322 LDS mutation results pre-
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262 SINGH, HILL, AND LINGAPPAdominantly in the accumulation of the 10S assembly
intermediate, with a small amount of Gag migrating in the
region of the second (80S) intermediate. These findings
were confirmed on gradients that produce optimal sep-
aration between the 10S and 80S peaks (data not
shown). Thus, it appears that residues in the distal re-
gion of CA around amino acid 322 also play a role in
promoting Gag–Gag interactions during the early steps
in the assembly pathway.
Effect of mutations in MA on capsid formation in the
cell-free system
FIG. 4. Velocity sedimentation analysis of the 322 LDS and D56–68
rogrammed with transcript encoding wild-type Gag or the 322 LDS an
t the end of the reaction, NP-40 was added to 1% and reaction pro
ontaining 1% NP-40, as described under Materials and Methods. The
nd expressed as a percentage of total synthesis for each reaction. R
ontrol three independent times; two representative experiments are
uantitated as shown in the bar graph and described under MaterialsHaving found that regions of CA and NC are important
for progression of assembly during the early stages ofGag multimerization, we examined whether deletions
and mutations in the amino-terminal MA region of Gag
have similar consequences. We had previously exam-
ined the effect of mutating the myristoylation signal at the
extreme N-terminus of MA on cell-free capsid assembly,
and found that it plays a role in progression beyond the
second (80S) assembly intermediate (Lingappa et al.,
1997). In the current study, we examined four additional
mutations in MA that were previously studied by others
in intact cells, which included point mutations in the
region of the first two cysteines in MA (residues 56 and
86, respectively) and deletions of two regions located in
ions in HIV-1 Gag. Cell-free translation and assembly reactions were
68 mutations, located in the CA and MA regions of Gag, respectively.
ere analyzed by velocity sedimentation on 13-ml sucrose gradients
t of radiolabeled translation product in each fraction was determined
ns and gradient analyses were performed in parallel with a wild-type
(open circles vs filled circles). Total cell-free reaction products were
ethods.mutat
d D56–
ducts w
amoun
eactiothe distal end of MA (residues 104–115 and residues
115–129, respectively).
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263EFFECT OF MUTATIONS ON CELL-FREE HIV-1 CAPSID ASSEMBLYDeletions and point mutations adjacent to either the
first or the second cysteine residue of MA were shown to
block viral particle release in mammalian and insect
cells (Freed et al., 1994; Chazal et al., 1995). Interestingly,
ltrastructural examination revealed that these block-
des occur for different reasons. When the region around
ys 56 is mutated, no completely formed capsids are
een within cells by EM, while mutations surrounding
ys 86 result in high levels of capsid formation occurring
lmost exclusively at cytoplasmic vacuoles rather than at
he plasma membrane (Freed et al., 1994). Deletion of
mino acids 104–115 in MA was also shown to redirect
he location of capsid assembly (Chazal, 1995), as was
eletion of even larger sections of MA (Facke et al.,
993). In contrast, deletion of amino acids 115–129 within
A has no effect on the amount or location of particle
ssembly or on particle release (Chazal et al., 1995).
hese findings indicate that mutations surrounding cys
6 produce defects in capsid assembly per se, while
utations surrounding cys 86 as well as deletion of
esidues 104–115 primarily cause defective targeting of
ag polypeptides, with a resulting failure in particle
elease. Particles formed when assembly is redirected to
ytoplasmic vacuoles appear to be morphologically ab-
rrant by EM (Freed et al., 1994; Facke et al., 1993). It is
nclear whether this abnormal morphology is a conse-
uence of altered budding and envelopment, or whether
t results from an additional, independent defect in cap-
id formation that is also caused by these mutations.
xamination in the cell-free system could be useful for
dentifying whether mutations that redirect targeting of
ag chains also produce defects in Gag–Gag interac-
ions.
Cell-free assembly reactions were programmed with
ranscript encoding wild-type Gag or transcript encoding
utations D56–68, 85YDG, and 88HDG, D104–115, or
D115–129. Each cell-free reaction was subjected to anal-
ysis by sucrose gradient sedimentation. As shown in Fig.
5, no discrete peak is seen in the region of 750S com-
pleted capsids when the reaction is programmed with
the D56–68 mutation. Instead there are large accumula-
tions of Gag-containing complexes in the previously de-
fined 10S, 80S, and 500S positions, and a trail extending
into higher S-value ranges. Similar results were obtained
when reactions were programmed with the point mutant
59 IDE (data not shown). The absence of completed
capsids is consistent with findings other investigators
obtained upon ultrastructural examination of intact cells
expressing these mutations. The accumulation of Gag-
containing complexes having values of S $ 80 indicates
that mutations in the region of cys 56 block the formation
of immature HIV-1 capsids by preventing proper multim-
erization of Gag chains at a relatively late point in the
cell-free assembly pathway. This differs from findings
obtained with the assembly-defective mutations in NC
and the distal portion of CA described above, in which allor the majority of Gag chains were found in 10S com-
plexes.
Cell-free reactions expressing mutations surrounding
cys 86 (Fig. 5) and deletions in more distal regions of MA
(Fig. 6) had a very different outcome than reactions
programmed with transcript encoding mutations sur-
rounding cys 56. Point mutations 85YDG and 88HDG
resulted in accumulation of 750S completed capsids to
an extent similar to that with wild-type Gag (Fig. 5).
Programming cell-free reactions with the point mutant
87VDE (data not shown) gave results identical to those
shown for 85YDG and 88HDG. In each case, residual
amounts of assembly intermediates were seen, as with
wild-type Gag (Fig. 5). Deletion of residues 104–115 also
gave results in the cell-free system that were indistin-
guishable from that of wild-type Gag (Fig. 6). These data
suggest that the mutations surrounding cys 86 as well as
deletion of residues 104–115, both of which are known to
redirect targeting of Gag chains to internal membranes,
do not alter Gag multimerization and assembly of the
immature capsid per se. Finally, we examined a deletion
in MA (D115–129) that has no effect on Gag targeting or
HIV-1 capsid formation in insect cells (Chazal et al.,
1995). We found that this mutation closely resembles
wild-type Gag when expressed in the cell-free system
(Fig. 6). Thus, the phenotype of this assembly-competent
mutation in Gag is also faithfully reproduced in the cell-
free system.
To determine whether the assembly-defective mutants
were stably arrested at specific points in the capsid
assembly pathway, or whether they slowly progress to
form completed capsids, cell-free reactions were ana-
lyzed by velocity sedimentation at both 150 and 300 min
after the start of the cell-free reactions. As shown in Fig.
7A, the total amount of 750S completed capsids pro-
duced in the cell-free reactions did not change signifi-
cantly after 150 min of incubation. Furthermore, assem-
bly-defective mutants were still blocked at the same
points in the assembly pathway when profiles were com-
pared at 150 vs 300 min into the reactions (Fig. 7B).
These findings demonstrate that assembly-defective mu-
tants do not progress further along the capsid assembly
pathway after the standard 150-min incubation period,
and confirm that assembly-defective mutants are indeed
trapped at specific stages of capsid assembly.
DISCUSSION
In this study, 12 well-characterized mutations in the
MA, CA, and NC regions of Gag were examined by
velocity sedimentation for their ability to form immature
capsids in the cell-free system. Previously only five mu-
tations in HIV-1 Gag were analyzed in cell-free systems
and reported (Spearman and Ratner, 1996; Lingappa et
al., 1997). Thus, this study adds significantly to our un-
derstanding of how mutations in Gag affect the behavior
ild-type
tated as
264 SINGH, HILL, AND LINGAPPAof newly synthesized Gag chains in eukaryotic cell ly-
sates. A chart of mutations in Gag that were studied in
both cellular and cell-free systems reveals that they
generally produce the same assembly phenotypes in the
cell-free system as they do in cells (Table 1). This finding
confirms and extends previous observations (Lingappa
et al., 1997) that the cell-free system faithfully reproduces
cellular events in immature capsid assembly and, there-
fore, constitutes an excellent system for understanding
posttranslational biochemical events in capsid forma-
tion.
Analysis in cellular systems by numerous groups re-
sulted in identification of mutations in Gag that block the
FIG. 5. Velocity sedimentation analysis of the 85YDG and 88HDG mutati
with transcript encoding wild-type Gag or the 85YDG and 88HDG mutation
to 1%, and reaction products were analyzed by velocity sedimentation on
Methods. The amount of radiolabeled translation product in each fractio
reaction. Reactions and gradient analyses were performed in parallel with a w
(open circles vs filled circles). Total cell-free reaction products were quantiproper formation of immature capsids. However, to date
such studies have not defined the mechanisms underly-ing such inhibition of capsid assembly. Our analysis of
posttranslational assembly intermediates in the cell-free
system indicates that assembly defects fall into relatively
distinct biochemical categories. The first category con-
sists of mutations that block progression beyond the first
and smallest (10S) posttranslational assembly interme-
diate (which is likely a Gag dimer). Truncations that
remove both cys-his boxes in NC as well as some or all
of the adjacent highly basic residues (i.e., Pr41 and
Pr41.9) block progression beyond the first (10S) assembly
intermediate in the cell-free system. In contrast, trunca-
tions that leave intact the entire first cys-his box and its
adjacent highly basic residues (Pr44.2 and Pr44.3) result
IV-1 Gag. Cell-free translation and assembly reactions were programmed
ted in the MA region of Gag. At the end of the reaction, NP-40 was added
crose gradients containing 1% NP-40, as described under Materials and
determined and expressed as a percentage of total synthesis for each
control three independent times; two representative experiments are shown
shown in the bar graph and described under Materials and Methods.ons in H
s, loca
13-ml su
n wasin proper formation of the 80S intermediate as well as
completed capsids (Fig. 2).
ed in pa
as sh
265EFFECT OF MUTATIONS ON CELL-FREE HIV-1 CAPSID ASSEMBLYIn general, our results and those of other investigators
localize the domain important for Gag–Gag interactions
(I domain) to the N-terminal residues of NC (Jowett et al.,
1992; Zhang and Barklis, 1997; Dawson and Yu, 1998;
Sandefur et al., 1998, 2000). However, there are some
differences in findings obtained with truncation around
residue 390. One group, studying expression in insect
cells, found that truncation of Gag at residue 390 results
in formation of particles that migrate quite differently
from wild-type particles in velocity sedimentation gradi-
ents (migrating in 30 vs 45% sucrose) (Jowett et al., 1992).
Two other groups found that, when Gag is terminated at
residue 391, the density of resulting immature particles is
similar to that of comparable wild-type particles (Zhang
and Barklis, 1997; Sandefur et al., 1998, 2000). Finally, our
FIG. 6. Velocity sedimentation analysis of the D104–115 and D115–12
programmed with transcript encoding wild-type Gag or the mutations D10
NP-40 was added to 1%, and reaction products were analyzed by velocit
under Materials and Methods. The amount of radiolabeled translation pr
synthesis for each reaction. Reactions and gradient analyses were perform
experiments are shown. Total cell-free reaction products were quantitatedresults indicate that proper capsids fail to form in the
cell-free system upon truncation at residue 390. Notethat our analysis examines the velocity sedimentation
characteristics of detergent-resistant complexes, and
therefore measures the integrity of the Gag-containing
complexes and capsids in the absence of lipids. In con-
trast, the two other investigators measured velocity sed-
imentation (Jowett et al., 1992) or density (Zhang and
Barklis, 1997; Sandefur et al., 1998, 2000) of lipid-envel-
oped capsids. Thus, the differences are likely to be due
to different methods of analysis, with velocity sedimen-
tation revealing abnormalities that are not appreciated
using density measurements. Together the data suggest
that truncation around residue 390 leads to formation of
particles that contain some abnormalities, most likely in
the structure of the capsid. In general, all of these stud-
ies agree that the residues at the extreme N-terminus of
tions in HIV-1 Gag. Cell-free translation and assembly reactions were
nd D115–129, located in the MA region of Gag. At the end of the reaction,
entation on 13-ml sucrose gradients containing 1% NP-40, as described
each fraction was determined and expressed as a percentage of total
rallel with a wild-type control three independent times; two representative
own in the bar graph and described under Materials and Methods.9 muta
4–115 a
y sedim
oduct inNC are important for Gag–Gag interactions.
Our demonstration that increasing the length of NC
266 SINGH, HILL, AND LINGAPPAFIG. 7. Time course of assembly. Cell-free reactions were programmed with each of the assembly-defective mutants described in Figs. 2 through 6, as
well as with wild-type Gag and one assembly-competent mutant (Pr44.3). Equivalent aliquots were removed at 2.5 and 5 h into the reaction. NP-40 was added
to 1%, and reaction products were subjected to velocity sedimentation on 5-ml linear sucrose gradients, as described under Materials and Methods. The
amount of radiolabeled translation product in each fraction was determined. (A) Bar graph shows the amount of completely assembled capsid (750S peak,
fractions 8–15) present in each reaction at 2.5 h (solid bars) and at 5 h (hatched bars), expressed as a percentage of the total product. Values shown are
the means of three experiments, and error bars indicate standard error. (B) Line graphs show the amount of radiolabeled product (x-axis) present in each
fraction (y-axis) as a percentage of total, at 2.5 h (filled circles) and at 5 h (open circles) for three assembly-defective mutants (Pr41.9, D56–68, and 322 LDS)
and one assembly-competent mutant (Pr44.3). Reactions were performed three independent times; data are from two representative experiments.
267EFFECT OF MUTATIONS ON CELL-FREE HIV-1 CAPSID ASSEMBLYresults in progressively more formation of the second
(80S) assembly intermediate (Fig. 3) suggests that resi-
dues in NC proximal to the second cys-his box stabilize
Gag–Gag interactions and increase the likelihood of pro-
gression from the 10S complex to the 80S complex and
beyond. These findings are consistent with the results of
Sandefur et al. (2000), which demonstrated that basic
residues between residues 384 and 391, as well as
residues in the first cys-his box and the basic linker
region in NC, contribute to I domain function. Our results
suggest that formation of the 80S intermediate may be a
critical early step in assembly that is important for sub-
sequent production of immature capsids of the correct
TABLE 1
The Effect of Mutations in HIV Gag on Capsid Formation
in the Cell-Free System and in Intact Cells
Plasmid
Capsid assembly
Cell-free Cells
WT Gag 1 1
NC
Pr46 1 1
Pr45 1 1
Pr44.3 1 1
Pr44.2 1 1
Pr41.9/Pr42 2 6
Pr41.0 2 2
CA
322LDS 2 2
D250–260 2 2
MA
D115–129 1 1
D104–115 1 1
88HDG 1 1
87VDE 1 1
85YDG 1 1
D56–68 2 2
59IDE 2 2
2GDA 2 2
Note. Sixteen mutations in Gag were analyzed in the cell-free system
as well as in intact cells. Analyses of cell-free reactions programmed
with four of these mutants (Pr46, Pr41, D240–250, and 2GDA) were
described previously (Lingappa et al., 1997) and the remaining muta-
tions are described in this report. Cellular studies were performed by
others, as follows: NC truncation mutants: Gheysen et al., 1989; Royer
et al., 1991; Jowett et al., 1992; Hockley et al., 1994; Spearman et al.,
1994; Zhang and Barklis, 1997; Dawson and Yu, 1998; Sandefur, et al.,
1998; Sandefur et al., 2000; CA mutations: Hong and Boulanger, 1993;
Hockley et al., 1994; Zhao et al., 1994; MA mutations: Gottlinger et al.,
1989; Bryant and Ratner, 1990; Freed et al., 1994; Chazal et al., 1995;
Facke et al., 1993. Mutations that result in the formation of completed
cell-free capsids or capsids that closely resemble wild-type in cells are
indicated with a plus, while those mutations that completely block
capsid formation are indicated with a minus. For truncations in the
region around residue 390 (Pr41.9 or Pr 42), different results were
obtained in cellular systems (indicated by 6), as described in detail in
the text.size.
Another mutation that appears to block capsid forma-tion at the first step in the assembly pathway is the 322
LDS mutation, located in the distal region of CA, near NC.
This mutation appears to produce a less-complete block-
ade than that produced by the truncation mutants Pr41
and Pr41.9, since a small amount of Gag accumulates in
the position of the second (80S) assembly intermediate.
These data suggest that both NC and the distal portion of
CA play an important role in early events in Gag multim-
erization. It remains to be determined whether one or
both of these regions assist in progression from the 10S
to 80S assembly intermediate by binding to other Gag
polypeptides, associating with a host factor necessary
for capsid formation, binding to RNA, or performing a
combination of these functions. Our demonstration that
these regions are involved in Gag–Gag interactions that
occur early in assembly will help to resolve these unan-
swered mechanistic questions.
The second category of defects in capsid assembly
involves blockade of Gag multimerization after formation
of the second (80S) assembly intermediate. The mutation
that best exemplifies this category is the previously de-
scribed 2GDA mutation (Lingappa et al., 1997), since it
produces large accumulations of only the 10S and 80S
assembly intermediates. This mutation, in which the my-
ristoylation signal is abolished by substituting the glycine
at residue 2 of Gag with alanine, results in production of
nonmyristoylated Gag chains (reviewed in Freed, 1998;
Garnier et al., 1998). Like regions of NC and the distal
third of CA, the myristoylation domain appears to play a
role, directly or indirectly, in early events in Gag multim-
erization (Lingappa et al., 1997). Interestingly, the same
blockade is seen when myristoyl CoA is omitted from the
cell-free reaction programmed with wild-type Gag (Lin-
gappa et al., 1997), confirming that absence of the my-
ristate moiety is the reason that 2GDA chains fail to
progress beyond the 80S assembly intermediate. Note
that the 322LDS mutation bears some resemblance to
2GDA, since it results in formation of a small amount of
the 80S Gag-containing complex, albeit much less than
is seen with 2GDA.
Blockade of multimerization after Gag chains have
formed the first two assembly intermediates constitutes
the third documented category of Gag multimerization
defects. As shown in this study, a deletion in the region
of the first cysteine residue in MA produces this defect,
resulting in formation of Gag-containing complexes of
greater than 80S but no completed 750S capsids. A
region located in the middle of CA (residues 250–260)
constitutes another domain in Gag that appears to be
involved in late events in Gag multimerization in the
cell-free system, as described previously (Lingappa et
al., 1997). Interestingly, neither point mutations around
the second cysteine residue in MA nor deletion of resi-
dues 104–115 in MA has any effect on early or late events
in Gag multimerization in the cell-free system. Others
showed that mutations in these regions block particle
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268 SINGH, HILL, AND LINGAPPArelease by redirecting Gag chains to internal cellular
membranes (Freed et al., 1994; Chazal et al., 1995). Our
findings demonstrate that these mutations do not affect
Gag multimerization and capsid formation per se.
The studies of numerous investigators (e.g., Gheysen
et al., 1989; Gottlinger et al., 1989; Bennett et al., 1993;
ong and Boulanger, 1993; Wang and Barklis, 1993;
orfman et al., 1994; Franke et al., 1994; Spearman et al.,
1994; Zhang et al., 1996; Borsetti et al., 1998; Sandefur et
al., 1998, 2000; Accola et al., 2000) support the idea that
only a small number of domains in Gag are required for
HIV-1 particle assembly. These include the myristate
moiety (the M domain), the C-terminal third of CA, and a
portion of NC (the I domains). Despite some discrepan-
cies with regard to findings of various groups, there is
general agreement that these domains play key roles in
particle formation. Interestingly, our data in both this
study and a previous study (Lingappa et al., 1997) dem-
onstrate that specific mutations in each of these regions
results in accumulation of Gag-containing assembly in-
termediates of 80S or less, and therefore are involved in
facilitating early events in Gag multimerization. Studies
in cells suggest that the role of other regions of Gag in
assembly is more complicated. Such regions include
portions of MA distal to the M domain, and the proximal
half of CA. For example, although point mutations in MA
were previously found to alter particle production (e.g.,
Yuan et al., 1993; Freed et al.,; 1994; Chazal et al., 1995;
Ono et al., 1997), large deletions reveal that residues in
MA distal to the M domain are not necessary for particle
formation or release (e.g., Wang et al., 1993; Lee and
ineal, 1994; Borsetti et al., 1998; Reil et al., 1998; Accola
t al., 2000). Our findings to date suggest that mutations
n such regions (including residues in MA distal to the M
omain, and in the proximal portion of CA) either have no
ffect on Gag multimerization or have effects at relatively
ate times during capsid formation.
MATERIALS AND METHODS
lasmid constructions
Plasmid vectors were derived from SP64 vector (Pro-
ega, Madison, WI) into which the 59 untranslated re-
ion of Xenopus laevis globin had been inserted at the
indIII site (Melton et al., 1984). The gag ORF from SF2
IV type 1 genomic DNA (a gift of Jay Levy) was intro-
uced downstream from the SP6 promoter and the glo-
in untranslated region as previously described (Lin-
appa et al., 1997). Plasmids expressing mutations in
ag were constructed using standard nucleic acid tech-
iques (Sambrook et al., 1989). The Pr45, Pr44.3, Pr44.2,
nd Pr41.9 truncation mutants were made from the wild-
ype construct by using PCR to introduce stop codons (in
old) in Gag after the following residues: thr 429 (DNA
equence of mutant from bp 1280: AT TGC ACT TAG
AA), trp 416 (DNA sequence of mutant from bp1240: sGC TGT TGG TAG TAA), gly 414 (DNA sequence of
utant from bp1235: AA AAG GGC TAG TAA), and lys
90 (DNA sequence of mutant from bp 1165 AGA AAG
AG). Deletions were made using a site-directed mu-
agenesis kit from Stratagene (La Jolla, CA). For the
56–68 construct, amino acids cys 57 through ser 67
ere deleted (DNA sequence of mutant from bp 160: TCA
AA GGC CTT CAG ACA GGA TCA); for D104–115, amino
cids glu 104 through lys 114 were deleted (DNA se-
uence of mutant from bp307: AAG ATT GCG CAG); and
or D115–129, amino acids gln 116 through val 130 were
eleted (DNA sequence of mutant from bp 330: A AGT
AG AAG AAG GCT AGC CAG AAT). Site-directed mu-
agenesis was also used to create the following single
mino acid mutations: substitution of ile at position 59
ith glu (59IDE) (DNA sequence of mutant from bp 170:
C CGC CAA GAA CTT GGA CAG); substitution of tyr at
osition 85 with gly (85YDG) (DNA sequence of mutant
rom bp 250: ACC CTC GGG TGT GTA); substitution of val
t position 87 with glu (87VDE) (DNA sequence of mutant
from bp 259: TGT GAA CAT CAA); substitution of his at
position 88 with gly (88HDG) (DNA sequence of mutant
from bp 260: GT GTA GGT CAA); and substitution of leu
with ser at position 322 (322LDS) (DNA sequence of
mutant from bp 965: CC TTG AGC GTC CAA). All point
mutations and deletions were confirmed by DNA se-
quencing.
Cell-free reactions
Transcription in the cell-free system with SP6 polymer-
ase was carried out at 40°C for 75 min. For Figs. 1, 2, 4,
5, and 6, translation of the transcription product was
performed using wheat germ extract in the presence of
35S-methionine at 26°C for 150 min as previously de-
cribed (Lingappa et al., 1997). For all cell-free reactions,
he total amount of translated product was determined by
nalyzing a microliter of translation product by SDS–
AGE and autoradiography, followed by quantitation of
he bands seen using densitometry. Translations were
djusted so that the amount of total translation product
as the same for all reactions. Each mutation in Gag
as expressed in the cell-free system and subjected to
radient analysis at least three independent times. All
xperiments included a wild-type Gag (WT) control. For
nalysis of the 80S intermediate in Fig. 3, incubations
ere performed for 45 min, adjusted to 10 mM EDTA, and
nalyzed on sucrose gradients as described below. For
ig. 7, cell-free reactions were performed as described
bove, and 10 aliquots were removed for gradient anal-
sis at the standard time of 150 min as well as at 300 min,
s indicated.
radient analysisGradient solutions were made using sucrose dis-
olved in buffer containing 100 mM NaCl, 4 mM MgAc,
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269EFFECT OF MUTATIONS ON CELL-FREE HIV-1 CAPSID ASSEMBLY50 mM KAc, 1% NP-40, and 10 mM TrisAc at pH 7.4. By
the use of a gradient maker, 13-ml continuous 15–60%
sucrose gradients were prepared. A 10-ml aliquot of
translation product from each of the cell-free reactions
was diluted into 100 ml of NP-40 buffer and layered onto
gradients. All samples in Figs. 1, 2, 4, 5, and 6 were
centrifuged on these gradients at 35,000 rpm using a
SW40 Ti rotor (Beckman Instruments, Fullerton, CA) for
95 min at 4°C, except for Spin 2 in Fig. 1B, which was
centrifuged on these gradients at 40,000 rpm for 130 h in
the SW40 Ti rotor. Samples in Fig. 7 were centrifuged on
5-ml linear 15–60% sucrose gradients at 45,000 rpm for
45 min in the MLS50 rotor. Fractions (350 ml) were
collected from the top of all gradients with a Haake-
Buchler gradient fractionator. After fractionation, either
the entire fraction was TCA-precipitated, washed with
ethanol, and analyzed by SDS–PAGE, or an aliquot of the
fraction was directly analyzed by SDS–PAGE. SDS–PAGE
was performed using 15% acrylamide gels and the ra-
diolabeled products were visualized by autoradiography.
For Fig. 2, discontinuous 2-ml 10–50% sucrose gradi-
ents were used to resolve 10S vs 80S assembly interme-
diates. A 10-ml aliquot of the cell-free reaction product
as diluted into 100 ml of NP-40 buffer and layered onto
gradients, which were centrifuged at 55,000 rpm in a
Beckman TLS55 rotor for 1 h at 4°C. Ten fractions of 200
ml were collected from the top of the gradient and ana-
lyzed by SDS–PAGE and autoradiography.
The methods of S-value determination (McEwen, 1967)
and standardization using S-value markers were de-
scribed previously (Lingappa et al., 1997).
Image analysis
Autoradiographs were digitized using Arcus II scanner
(AGFA) and Adobe Photoshop software (Adobe Systems,
Mountain View, CA). Mean band densities were obtained
and the background was subtracted.
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